z-logo
open-access-imgOpen Access
Retracted: The MEK1/2 Inhibitor AZD6244 Sensitizes BRAF-Mutant Thyroid Cancer to Vemurafenib
Author(s) -
Hao Song,
Jinna Zhang,
Ning Liang,
Honglai Zhang,
Dong Chen,
Xuelong Jiao,
Kejun Zhang
Publication year - 2022
Publication title -
medical science monitor
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.636
H-Index - 85
eISSN - 1643-3750
pISSN - 1234-1010
DOI - 10.12659/msm.936571
Subject(s) - vemurafenib , cancer research , medicine , zhàng , papillary thyroid cancer , cancer , thyroid cancer , political science , metastatic melanoma , law , china

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom